1. Introduction {#sec1}
===============

Methionine (Met) is involved in several crucial functions in poultry, which include protein synthesis, lipid metabolism, innate immune system regulation, digestive functions, and altering the level of S-adenosylmethionine (SAM), thereby changing gene expression by DNA methylation reactions ([@bib12], [@bib15], [@bib14], [@bib21], [@bib33]).

DL-methionine (DLM) and DL-2-hydroxy-4-methylthio-butanoic acid (HMTBa) are 2 commonly used Met additives ([@bib1]). DL-methionine and HMTBa are structurally different molecules with different physiological characteristics ([@bib23], [@bib34]), and have different optimum dietary levels in poultry. Better growth performance, improved feed conversion ratio (FCR), and lower mortality have been reported in broilers under heat stress or when birds were fed low protein diets supplemented with HMTBa compared with DLM ([@bib22], [@bib27]). DL-2-hydroxy-4-methylthio-butanoic acid and DLM can produce cysteine (Cys), a precursor of glutathione (GSH), which can then be converted into taurine and GSH ([@bib27], [@bib26]). However, HMTBa exhibits greater conversion efficiency ([@bib11]). DL-2-hydroxy-4-methylthio-butanoic acid supplementation produces less homocysteine in the plasma than DLM ([@bib29]) and improves L-methionine conversion for effective utilization in chicken livers ([@bib5]). Furthermore, Met serves as an antioxidant, thereby eliminating reactive oxygen species (ROS) by Met residues or through GSH synthesis ([@bib26], [@bib32]).

The significance of Met sources in animal production necessitates an in-depth investigation about their role in antioxidant response in broilers. Therefore, the present research evaluated the effect of different Met sources and levels in broiler diets on growth performance, redox status in different tissues, metabolism pathways and absorption processes.

2. Materials and methods {#sec2}
========================

All the procedures adopted in carrying out this experiment were approved by the China Agricultural University and conducted in accordance with the Guidelines for Experimental Animals.

2.1. Birds and experimental diets {#sec2.1}
---------------------------------

DL-methionine (99%, Sumitomo Chemical, Japan) and HMTBa (effective content 88%; Adisseo, France) were obtained from the market.

A 2 × 2 factorial experiment with 2 sources (DLM and HMTBa) and 2 supplementation levels (0.05% and 0.25%) of Met was conducted. A total of 480 one-day-old male AA + broiler chicks with similar body weight (BW) were randomly divided into 4 treatments. Each treatment consisted of 8 replicates (15 chickens per replicate). A corn-soybean meal-based diet without supplementation of any synthetic Met served as a basal diet. Synthetic Met (DLM and HMTBa) were added to the basal diet on an equimolar basis at 0.05% and 0.25% Met equivalents. The experimental diets were formulated in accordance with the Feeding Standards of Broilers (NY/T 33-2004). All the nutrients (except Met) met the broiler starter phase requirement ([Table 1](#tbl1){ref-type="table"}).Table 1Ingredients composition (calculated and analyzed nutrients) of the experimental diets for broilers at 1 to 21 d of age (%, as-fed basis).Table 1IngredientsContentCalculated nutrientsContentMaize54.50ME, Mcal/kg2.97Soybean meal37.00Crude protein21.53Soybean oil2.50Calcium1.00Wheat middling2.00Available phosphorus0.45Dicalcium phosphate1.85Lysine1.29Limestone1.24Methionine0.32Salt0.35Cysteine0.34Choline chloride 50%0.20Threonine0.82Trace mineral premix[1](#tbl1fn1){ref-type="table-fn"}0.20Tryptophan0.26L-lysine HCl 78%0.13Vitamin premix[2](#tbl1fn2){ref-type="table-fn"}0.03Total100[^1][^2][^3]

2.2. Animal management {#sec2.2}
----------------------

All the birds were raised on wire net floors in an environmentally controlled house under 23 h continuous light and 1 h darkness. The room temperature was initially set at 33 °C and then gradually reduced according to the age of the birds until reaching 23 °C on d 21. Feed and water were provided *ad libitum*. The birds were weighed on d 1 and then on d 21 after 6 h fasting to calculate body weight gain. Feed intake from d 1 to 21 was also recorded to calculate average daily gain (ADG), average daily feed intake (ADFI), FCR, and European composite index (ECI).

2.3. Sample collection {#sec2.3}
----------------------

On d 21, one bird per replicate from each treatment was anesthetized with 50 mg/kg pentobarbital sodium (Sigma, St. Louis, MO, USA). Blood was collected from the jugular vein, and stored at −20 °C after centrifugation (3,000 × *g* for 10 min at 4 °C). Liver samples (2 g) were collected, 8 to 10 mm segments of the small intestine were opened and flushed with cold phosphate buffered saline. Mucosa from the middle duodenum, jejunum, and ileum was collected by gentle scraping with a microscope slide. Liver samples were snap-frozen in liquid N~2~, and stored at −80 °C for further analysis.

2.4. Redox balance {#sec2.4}
------------------

An enzyme recycling method was used to test the GSH content in serum, mucosa and liver samples according to the manufacturer\'s recommendations (T-GSH assay kit; Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Total glutathione (T-GSH) was tested using a bicinchoninic acid (BCA) Protein Assay Kit (CWBIO, Beijing, China), and expressed relative to the protein concentration in the samples. Glutathione peroxidase (GPx) activity in the plasma, mucosa, and liver was measured by kits (Nanjing Institute of Bioengineering, Nanjing, China). Glutathione and oxidized glutathione (GSSG) contents in the serum, mucosa, and liver were measured using a Pik Wan-day Biotechnology Company kit.

2.5. Small intestinal met transporter and antioxidant-related gene expression {#sec2.5}
-----------------------------------------------------------------------------

The total RNA of the duodenum, jejunum, ileum, and liver was extracted using Trizol reagent (TAKARA, Japan). The specific procedure has been described in the supplementary material of the kit. The RNA purity and concentration was determined by a nucleic acid analyzer (Nano-drop 2000). cDNA was synthesized using a reverse transcription kit (TAKARA, Japan) and the reversed product was stored in a refrigerator at −30 °C. Fluorescence quantitative PCR was performed according to the SYBP Premix ExTaq (TAKARA, Japan) manual. The reaction instrument was a 7500-fluorescence detection system (Applied Biosystems). The PCR conditions were as follows: 95 °C pre-denaturation for 30 s, denatured at 95 °C for 5 s, 40 cycles of reaction. After PCR amplification, the dissolution curve was observed and agarose gel electrophoresis was used to identify whether the amplified gene fragment was as designed to verify the specificity of the amplified product. The amino acid and antioxidant-related genes of Na^+^ dependent neutral amino acid transporter (*B*^*0*^*AT*), Na^+^ and Cl^−^ dependent neutral and cationic amino acid transporter (*ATB*^*0*,\ *+*^), Na^+^-independent cationic and zwitterionic amino acid transporter (*b*^*0*,\ *+*^ *AT*), diamine acetyltransferase 1 (*SAT1*), Na^+^-independent branched-chain and aromatic amino acid transporter (*LAT1*), Na^+^-independent cationic and Na^+^-dependent neutral amino acid (*y*^*+*^ *LAT2*), proton dependent monocarboxylate transporter 1 (*MCT1*), Na^+^-H^+^ exchanger (*NHE3*), methionine adenosyltransferase 1 (*MAT1*), methionine sulfoxide reductase *A* (*MrsA*), thioredoxin (*Trx*), glutaredoxin (*Grx*), glutathione reductase (*GSR*), glutathione synthetase (*GSS*) and glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*) primers are shown in [Table 2](#tbl2){ref-type="table"}. The results of the genes expression were analyzed by 2^-△△CT^.Table 2Primer sequences of fluorescence quantitative PCR.Table 2TargetAccession No.Forward (5′ to 3′)Reverse (5′ to 3′)*B*^*0*^*AT*[XM_419056.4](ncbi-n:XM_419056.4){#intref0015}GGGTTTTGTGTTGGCTTAGGAATCCATGGCTCTGGCAGAGAT*ATB*^*0*,*+*^[XM_004940661.1](ncbi-n:XM_004940661.1){#intref0020}TGGCAACATCGTGTGGTACCTAGGCAGCTCCAACGATCATC*b*^*0*,*+*^*AT*[NM_004935075.1](ncbi-n:NM_004935075.1){#intref0025}CAGTAGTGAATTCTCTGAGT GTGAAGCTGCAATGATTGCCAC AACTACCA*SAT1*[NM_001199603.1](ncbi-n:NM_001199603.1){#intref0030}CACAGTGCCAGTGCTGTTTTT CTGTTTTTCTTGCCAGCTCGAA*LAT1*[NM_001030579.1](ncbi-n:NM_001030579.1){#intref0035}GATTGCAACGGGTGATGTGACCCCACACCCACTTTTGTTT*y*^*+*^*LAT2*[XM_001231336.3](ncbi-n:XM_001231336.3){#intref0040}GCCCTGTCAGTAAATCAGACA AGATTCAGTTGCATTGTGTTT TGGTT*MCT1*[NM_001006323.1](ncbi-n:NM_001006323.1){#intref0045}AGCAGCATCCTGGTGAACAAGAGGCACCCACCCACGAT*NHE3*[XM_001199133.1](ncbi-n:XM_001199133.1){#intref0050}AGGCTGGACCGGTTTGCTCCCGAATACTTTTCCTCCTTTG*MAT1*[NM_001199519.1](ncbi-n:NM_001199519.1){#intref0055}CCAGGTTAGCAGAGCTGAGGATGGACACGCACTGGTATGA*MrsA*[XM_004935891.2](ncbi-n:XM_004935891.2){#intref0060}CTGGCCACACAGAGGTTGTAAGTCATTACCTTGCCGCATT*Trx*[NM_205453.1](ncbi-n:NM_205453.1){#intref0065}GATTTCTCTGCCACATGGTGTATCTTGGGCATCATCCACAT*Grx*[NM_205160.1](ncbi-n:NM_205160.1){#intref0070}CCGTCCCTCGTGTGTTTATTCACCAGAGCACCAATTTGAC*GSR*[XM_015276627.1](ncbi-n:XM_015276627.1){#intref0075}GTGGTTACGGCAAGTTCACCCACAGTCAGGAGGGACCACT*GSS*[XM_425692.5](ncbi-n:XM_425692.5){#intref0080}TTGCTGGGCTGTACTCACTGACAGGTTGTTCCCTCCTCCT*GAPDH*[K01458](ncbi-n:K01458){#intref0085}TGCTGCCCAGAACATCATCCACGGCAGGTCAGGTCAACAA[^4]

2.6. Statistical analysis {#sec2.6}
-------------------------

Two-factor analysis was performed using the general linear model (GLM) procedure of SPSS 23.0 (IBM, Armonk, New York, US). The results were expressed as means. Grubbs method was used to eliminate the abnormal values of data. Significant means were separated by Duncan\'s Multiple Range test method. The significance level was *P* ≤ 0.05, whereas *P* \< 0.1 was considered as a tendency of significant difference.

3. Results {#sec3}
==========

3.1. Growth performance {#sec3.1}
-----------------------

Growth performance results are presented in [Table 3](#tbl3){ref-type="table"}. A source × level interaction was observed on ADFI, BW, and ADG, and these indexes improved (*P* \< 0.05) when broilers were fed diets with higher HMTBa supplementation levels. Similarly, high Met supplementation levels improved (*P* \< 0.05) BW, ADG, FCR and ECI of broilers.Table 3Effects of 2 sources and levels of methionine on the growth performance in broilers on d 21.Table 3SourceLevel, %BW, gADG, gADFI, gFCREuropean composite indexDLM0.05795.09^ab^35.76^ab^54.15^ab^1.55219.800.25798.38^ab^35.93^ab^53.32^ab^1.49230.55HMTBa0.05779.29^a^35.02^a^53.03^a^1.52217.990.25815.78^b^37.10^b^54.47^b^1.48240.04SEM5.230.250.330.013.86Main effect SourceDLM796.7335.8454.001.51227.77HMTBa801.0936.0653.851.50230.30 Level, %0.05787.19^a^35.39^a^53.851.52^b^221.49^a^0.25810.64^b^36.52^b^53.991.48^a^236.58^b^*P*-value Source0.6480.6280.8210.4770.733 Level0.0200.0190.8230.0160.049 Source × Level0.0420.0420.0290.9290.204[^5][^6]

3.2. Antioxidant properties in the serum, mucosa and liver {#sec3.2}
----------------------------------------------------------

An antioxidant property in broiler serum and livers is presented in [Table 4](#tbl4){ref-type="table"}. In the serum, no source × level interaction on the GPx activity was observed. The Met source did not affect the antioxidant property. However, GPx activity in the serum was increased (*P* \< 0.05) with high Met levels.Table 4Effects of 2 sources and levels of methionine on the antioxidant property in serum and liver of broilers on d 21.Table 4SourceLevel, %SerumLiverGPx, U/mLGPx, U/mg proteinT-GSH, nmol/gGSSG, nmol/gGSH, nmol/gGSH:GSSGDLM0.051,665.8930.741,733.23^a^428.81^a^875.614.100.252,639.7934.962,132.34^b^635.82^b^860.703.35HMTBa0.051,699.7732.471,512.09^a^423.15^a^665.793.630.252,457.0735.631,720.89^a^422.82^a^715.793.32SEM59.220.8063.3723.9432.800.06Main effect SourceDLM2,152.8433.351,932.79^b^532.32^b^868.15^b^3.73HMTBa2,078.4233.931,475.47^a^427.66^a^620.14^a^3.48 Level, %0.051,682.83^a^31.991,622.66425.98^a^770.703.86^b^0.252,548.43^b^35.291,785.60534.00^b^717.603.35^a^*P*-value Source0.5400.724\<0.0010.002\<0.0010.079 Level\<0.0010.0540.0950.0020.3320.001 Source × Level0.3740.9550.0190.0040.4840.100[^7][^8]

In the liver, the antioxidant status was affected by the dietary Met supplementation level and source. There was an interaction (*P* \< 0.05) on T-GSH, and GSSG. Total glutathione and GSSG were higher (*P* \< 0.05) in the 0.25% DLM group than that of the 0.05% DLM group and both HMTBa groups. Methionine sources affected (*P* \< 0.05) the hepatic GSH content. DL-methionine supplementation increased (*P* \< 0.05) GSH, GSSG, and T-GSH contents. High dietary Met supplementation levels improved (*P* \< 0.05) GSH:GSSG. Glutathione peroxidase activity in the liver remained unaffected by the Met source, although a slight improvement (*P* = 0.054) was observed in the liver with higher Met levels.

There was no interaction between the Met source and level on the T-GSH, GSH, and GSSG contents ([Table 5](#tbl5){ref-type="table"}). DL-methionine increased (*P* \< 0.05) the T-GSH and GSSG contents in the duodenal mucosa, and GSSG in the jejunal mucosa, and T-GSH, GSSG, GSH in the ileal mucosa compared with HMTBa. However, DLM decreased (*P* \< 0.05) the GSH:GSSG in the jejunal mucosa.Table 5Effects of 2 sources and levels of methionine on the glutathione levels in intestinal mucosa of broilers on d 21.Table 5SourceLevel, %Duodenal mucosaJejunal mucosaIleal mucosaT-GSH, nmol/gGSSG, nmol/gGSH, nmol/gGSH:GSSGT-GSH, nmol/gGSSG, nmol/gGSH, nmol/gGSH:GSSGT-GSH, nmol/gGSSG, nmol/gGSH, nmol/gGSH:GSSGDLM0.051,266.04541.78182.482.47970.55290.42389.713.38966.08239.04488.004.120.251,260.19569.2468.682.13734.70203.29328.123.73889.10216.68455.744.15HMTBa0.05981.87424.49142.892.36833.33210.02413.293.98669.07161.04346.984.150.25947.22466.1914.842.04666.78152.95360.884.56551.39152.94245.523.61SEM41.8123.5225.110.0637.6413.6717.260.1241.8110.2125.160.10Main effect SourceDLM1,252.39^b^563.41^b^125.582.30852.62246.85^b^358.913.56^a^927.59^b^227.86^b^471.87^b^4.14HMTBa969.54^a^445.34^a^78.872.20750.05181.48^a^387.094.27^b^610.23^a^156.99^a^296.25^a^3.88 Level, %0.051,128.95483.14162.68^b^2.42^b^901.94^b^250.22^b^401.503.68^a^817.57200.04417.494.140.251,092.98525.6141.76^a^2.09^a^700.74^a^178.12^a^344.504.15^b^720.25184.81350.633.88*P*-value Source\<0.0010.0150.3250.3660.1340.0060.4180.001\<0.001\<0.001\<0.0010.187 Level0.6090.3570.0150.0040.0050.0030.1070.0280.1250.3640.0950.189 Source × Level0.9020.9860.8800.9460.6060.4990.8940.5920.7440.6690.3790.151[^9][^10]

The GSH content and GSH:GSSG in the duodenal mucosa, and T-GSH and GSSG contents in the jejunal mucosa decreased (*P* \< 0.05) with increasing Met levels. However, GSH:GSSG in the jejunal mucosa increased (*P* \< 0.05) with high Met supplementation levels.

3.3. Antioxidant-related gene expression in the liver and intestine {#sec3.3}
-------------------------------------------------------------------

There was an interaction between the Met source and level on *Grx* gene expression in the ileum and *Trx* gene expression in the liver. DL-2-hydroxy-4-methylthio-butanoic acid supplementation at 0.25% increased (*P* \< 0.05) *Grx* gene expression compared with 0.05% or 0.25% DLM supplementation. The addition of 0.25% DLM decreased (*P* \< 0.05) *Trx* gene expression in the liver compared with 0.05% DLM, or 0.25% HTMBA supplementation ([Table 6](#tbl6){ref-type="table"}).Table 6Effects of 2 sources and levels of methionine on the antioxidant-related gene expression in intestine and liver of broilers on d 21.Table 6SourceLevel, %DuodenumJejunumIleumLiver*MAT1MrsATrxGrxGSRGSSMAT1MrsATrxGrxGSRGSSMAT1MrsATrxGrxGSRGSSMAT1MrsATrxGrxGSRGSS*DLM0.051.021.030.740.891.211.131.140.961.051.060.941.031.011.021.011.01^a^1.031.051.031.061.02^b^1.071.031.060.250.980.780.720.741.190.970.961.060.850.961.021.140.910.980.970.87^a^1.021.140.811.010.73^a^0.670.900.90HMTBa0.050.710.900.790.811.381.181.240.860.970.781.021.091.051.001.071.06^ab^1.181.361.251.310.86^ab^2.120.970.840.250.951.040.940.861.471.351.161.111.070.991.221.370.741.281.321.37^b^1.371.561.111.100.95^b^0.651.231.20SEM0.090.050.060.070.060.070.050.050.050.060.060.070.060.040.040.170.060.07Main effect SourceDLM1.070.840.72^a^0.811.301.121.200.960.880.860.940.970.940.970.94^a^0.92^a^0.97^a^1.04^a^0.94^a^1.040.900.830.991.00HMTBa0.810.960.86^b^0.831.491.321.180.930.980.831.061.120.891.160.89^b^1.26^b^1.28^b^1.48^b^1.16^b^1.160.901.231.140.97 Level, %0.050.910.910.760.801.431.290.921.350.950.820.941.011.020.981.011.021.051.151.17^b^1.140.971.41b1.061.000.250.960.890.820.851.361.160.971.040.900.861.051.080.811.151.141.171.201.370.93^a^1.060.830.64a1.070.97*P*-value Source0.1350.2560.0320.8330.3400.2580.9040.7190.4800.8280.3250.1740.5830.0580.0160.0080.0180.0030.0470.0780.9200.1510.1850.800 Level0.7540.8180.3570.6170.7190.4420.1250.6520.7250.7380.3490.5350.0510.0890.1500.2110.2470.1060.0440.2010.0550.0090.9390.808 Source × Level0.5520.0790.1290.9270.0780.0530.3410.4810.9240.9390.6240.5960.1980.1370.1810.0420.7320.9020.8200.5680.0050.1020.1060.220[^11][^12]

Methionine sources affected antioxidant gene expression in broiler intestinal mucosa and liver. Dietary supplementation with HMTBa increased (*P* \< 0.05) *Trx* gene expression in the duodenum, *Trx*, *Grx*, *GSR*, and *GSS* gene expression in the ileum, and *MAT1* gene expression in the liver than that of DLM.

Methionine levels had no effect on antioxidant gene expression in broiler intestinal mucosa and liver, except *MAT1* gene expression, which decreased (*P* \< 0.05) with increasing Met levels in the liver.

3.4. Amino acid transporter-related gene expression in the intestine {#sec3.4}
--------------------------------------------------------------------

There was an interaction (*P* \< 0.05) between the Met sources and levels on *b*^*0*,\ *+*^ *AT* and *MCT1* genes expression in the duodenum, and *SAT1* and *LAT1* in the ileum. Proton dependent monocarboxylate transporter 1 and *b*^*0*,\ *+*^ *AT* gene expression in the duodenum decreased (*P* \< 0.05) with increasing DLM levels, however, no differences were found between different HMTBa supplementation levels. Diamine acetyltransferase 1 gene expression increased (*P* \< 0.05) with increasing DLM supplementation levels, whereas, it decreased (*P* \< 0.05) with increasing HMTBa supplementation levels. No differences between 0.25% DLM and HMTBa were noted. Na^+^-independent branched-chain and aromatic amino acid transporter gene expression decreased (*P* \< 0.05) with increasing HMTBa levels, however, there were no differences between 2 levels of DLM ([Table 7](#tbl7){ref-type="table"}).Table 7Effects of 2 sources and levels of methionine on the amino acid transports gene expression in the intestine of broilers on d 21.Table 7SourceLevel, %DuodenumJejunumIleum*B*^*0*^*ATATB*^*0,+*^*b*^*0,+*^*ATSAT1LAT1y*^*+*^*LAT2MCT1NHE3B*^*0*^*ATATB*^*0,+*^*b*^*0,+*^*ATSAT1LAT1y*^*+*^*LAT2MCT1NHE3B*^*0*^*ATATB*^*0,+*^*b*^*0,+*^*ATSAT1LAT1y*^*+*^*LAT2MCT1NHE3*DLM0.051.061.241.03^b^0.931.110.941.081.351.091.210.910.951.071.031.081.040.940.930.951.01^a^1.04^a^1.041.091.070.250.880.710.59^a^0.800.950.690.761.070.881.411.110.891.070.911.161.081.022.100.791.28^bc^1.41^a^0.961.721.15HMTBa0.051.010.370.72^a^1.041.210.881.151.470.530.880.591.131.840.751.401.130.902.910.571.47^c^1.83^b^1.011.981.380.251.120.490.60^a^1.101.390.821.211.340.881.050.861.191.551.041.601.641.411.940.951.21^ab^1.32^a^1.212.301.50SEM0.070.140.050.060.080.050.090.110.090.130.100.040.100.060.100.110.090.340.080.050.080.080.110.10Main effect SourceDLM0.951.130.76^b^0.821.010.760.961.160.861.090.930.92a1.02a0.871.050.960.961.540.831.16^a^1.21^a^0.951.40^a^1.05HMTBa1.050.440.60^a^1.041.300.811.141.330.680.930.691.11b1.58b0.841.381.291.222.370.821.34^b^1.56^b^1.152.16^b^1.44 Level, %0.051.090.850.750.961.220.861.131.310.700.950.741.021.360.831.201.040.90^a^1.950.981.261.410.981.53^a^1.160.250.910.720.600.891.090.710.971.170.841.070.881.011.240.881.231.221.28^b^1.961.131.251.351.132.03^b^1.33P-value Source0.6130.0670.0330.1300.1740.6920.3400.4460.3240.5420.3160.0150.0200.8560.0720.1600.1200.2610.9120.0300.0210.231\<0.0010.062 Level0.3520.7190.0510.6230.5320.1700.4000.5100.4440.6480.5470.9670.6100.6750.8640.4270.0260.9900.1600.8480.6630.3520.0130.421 Source × Level0.0720.5080.0350.1740.1150.0940.0420.4550.6220.9980.7740.4600.1070.7450.2690.8370.1130.1360.0540.0050.0030.4160.4270.865[^13][^14]

Methionine sources affected amino acid transporter-related gene expression in the intestine. DL-2-hydroxy-4-methylthio-butanoic acid supplementation increased (*P* \< 0.05) *SAT1* and *LAT1* gene expression in the jejunum, and *MCT1* gene expression in the ileum (*P* \< 0.05). Amino acid transporter-related gene expression in the intestine was also affected by Met levels. *b*^*0*,\ *+*^ *AT* gene expression in the jejunum, and *MCT1* gene expression in the ileum increased (*P* \< 0.05) with increasing Met levels.

4. Discussion {#sec4}
=============

Methionine plays an important role in numerous biological processes ([@bib13]). Considerable research has demonstrated that optimum Met levels in poultry diets can improve growth performance, but there is continued controversy about the efficacy of synthetic Met sources i.e., HMTBa and DLM continues to persist ([@bib17], [@bib19]). It has been reported that both a deficiency and excess of dietary Met leads to poor broiler performance ([@bib21], [@bib32]).

Regarding Met, when dietary Met is supplemented at low levels, HMTBa is channelized to generate more Cys and taurine ([@bib11]). More than 50% Cys is used by the gastrointestinal tract ([@bib3]), leaving less Met for other organs, which subsequently affects growth performance ([@bib4]). Regarding sulfur amino acids (TSAA), HMTBa outperforms DLM when TSAA in the diet meets or exceeds the requirement, whereas DLM yields better results when the diet is low in TSAA ([@bib25]). [@bib10] reported that the biological requirement for total Met of broilers is 138 mg/d. [@bib6] recommended a Cys requirement is of 30.5 mg/d and TSAA requirement is of 132.25 mg/d for broilers. Notably, the Met intake (199 to 297 mg/d) in this study was higher than the recommendation. The biological efficiency of HMTBa has been reported to be 81% of the DLM value for ADG ([@bib19]). [@bib25] also reported that HMTBa may exert a similar effect on performance compared with DLM at high Met levels. Therefore, it was not unexpected that there was no difference in performance between DLM and HMTBa supplemented diets.

Apart from its role as an amino acid, Met is an important intermediate in methylation reactions and can be converted to Cys, which is required for GSH and taurine synthesis. Both GSH and taurine are important components in defense against oxidative stress. The antioxidant defense of the body relies both on non-enzymatic as well as enzymatic antioxidants, such as superoxide dismutase (SOD), catalase (CAT) and GPx. Glutathione provides protection against cellular oxidants through non-enzymatic interactions and enzymatic-mediated mechanisms. The present study showed that the liver and intestinal GSH system was influenced by the Met sources and levels in the diet. [@bib29] reported that the addition of high Met levels resulted in high homocysteine levels, which is toxic and results in neurodegenerative disease by impeding endothelium functions and ROS generation ([@bib24]). The Met metabolite, SAM can enter the irreversible transsulfuration pathway to form Cys, a constituent of GSH ([@bib31]). The present findings showed that HMTBa has a protective role on the intestinal epithelial barrier function, which is correlated with reduced GSH. Broilers fed HMTBa diets developed a better non-enzymatic antioxidant defense mechanism, which was consistent with the results of [@bib27]. Previous research has shown that HMTBa tends to metabolize in the sulfur pathway to improve the antioxidant capacity of body ([@bib11], [@bib9]). Hence, it can be inferred that HMTBa might be more beneficial than DLM in protecting cells from ROS. In addition, a reduction of the GSH:GSSG pool is associated with growth stimulation by nutrients. The GSSG content in the liver and intestinal mucosa was higher in DLM at the 0.25% level. Cellular GSSG levels are normally kept low by the action of GSH reductase, as high GSSG levels are toxic to cells. Additionally, HMTBa at different supplementation levels could maintain a stable GSSG level, which indicated that HMTBa yields better results in response to oxidative stress.

Under lower Met conditions, antioxidant defense systems in broilers were activated, which was evident by a lower GPx content in the serum and higher GSH:GSSG in liver. [@bib28] reported that a Met deficiency reduced the GPx and SOD activities and increased the MDA content in the spleens of broilers, but high dietary Met levels enhanced the serum SOD activity and ferric reducing ability, whereas, the MDA content was reduced ([@bib9], [@bib30]). Consistent with previous studies, we found that the addition of high Met supplementation levels could strengthen the antioxidant system by enhancing SOD activity in the duodenum, CAT in the ileum, as well as GPx activity and total antioxidant capacity in the serum.

Thioredoxin, as an important enzyme-regulated protein, aids in alleviating intracellular oxidative stress, controls growth and programmed cell death, participates in DNA synthesis, reduces the disulfide bond in the protein thereby, playing an important role in the body\'s antioxidant system ([@bib18]). [@bib8] reported that HMTBa can alleviate heat-induced oxidative damage by improving *Trx* in broilers. Our findings are supported by their work, where HMTBa enhanced *Trx* gene expression in broiler duodenum. However, no effect was observed on GSH in this study, which suggested that HMTBa controls the oxidative balance of cells by stimulating *Trx* gene expression in the duodenum rather than solely being involved GSH production. S-adenosylmethionine, synthesized by Met and ATP through L-methionine S-adenosyltransferase (MAT) catalysis, is an important methyl donor that can improve SOD activity ([@bib34]). We also found that HMTBa supplementation can improve *MAT1* expression in the liver, but decrease T-GSH, GSSG, and GSH contents. The underlying reason may be the participation of HMTBa in another metabolic pathway to produce SAM, whereas DLM generally generates GSH. We also found that compared with HMTBa, DLM supplementation can enhance GSSG and T-GSH contents in the duodenum and increase GSSG content and decrease GSH:GSSG in the jejunum.

Different mechanisms for cellular absorption, transport, metabolism and bio-efficiency exist for these 2 Met sources. Moreover, there are differences in their utilization among various species such as chickens, pigs and ruminants. As a Met precursor, HMTBa is absorbed mainly by MCT1, coupled with the NHE3 activity, and DLM uptake occurs via multiple carrier-mediated systems. The liver, kidneys and small intestine can metabolize D-Met and HMTBa to L-Met through oxidation and transamination. Unlike DLM, which can only be transported into the body via active transport, HMTBa can either be absorbed into the body by active transport or by passive diffusion through the intestinal epithelial cells into the bloodstream and transported to other tissues ([@bib34]). The major Met transporter present on the brush border of the intestinal epithelial cells include B^0^AT, ATB^0,+^and b^0,+^AT ([@bib16]). The transporters present on the basal membrane mainly include SAT1, SAT2 and SAT3, and LAT1 and LAT2, and y^+^ LAT1 and y^+^ LAT2. It was noted that dietary supplementation with DLM enhanced *ATB*^*0*,+^ and *B*^*0*^*AT* expression in the duodenum, whereas dietary HMTBa supplementation mainly improved the expression of *SAT1* and *LAT1* in the jejunum and *SAT1*, *LAT1* and *MCT1* in the ileum, which showed that DLM is mainly absorbed in the duodenum whereas the jejunum and ileum are the main sites HMTBa absorption. This concurs with [@bib11], who also reported that the jejunum and ileum had higher HMTBa absorption. In addition, DLM can improve the transporters present on the brush border, whereas, HMTBa tends to enhance the transporters on the basement membrane. Thus, transporters present on the basement membrane transport HMTBa more efficiently to blood to participate in the metabolism. In this way, more HMTBa escapes the first-pass effect in the gastrointestinal tract and is utilized by whole body tissues ([@bib7]).

5. Conclusion {#sec5}
=============

DL-methionine is mainly absorbed in the duodenum and favors GSH synthesis, whereas HMTBa is primarily absorbed in the jejunum and ileum and generates SAM; thus, stimulates *Trx* expression, which in turn participates in oxidation resistance.
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[^1]: ME = metabolizable energy.

[^2]: Trace mineral supplied per kilogram of diet: Cu, 8 mg; Zn, 75 mg; Fe, 80 mg; Mn, 100 mg; Se, 0.15 mg; I, 0.35 mg.

[^3]: Vitamin premix supplied per kilogram of diet: vitamin A, 12,500 IU; vitamin D~3~, 2,500 IU; vitamin E, 18.75 mg; vitamin K~3~, 2.65 mg; vitamin B~1~, 2 mg; vitamin B~2~, 6 mg; vitamin B~6~, 6 mg; vitamin B~12~, 0.025 mg; biotin, 0.0325 mg; folic acid, 1.25 mg; pantothenic acid, 12 mg; nicotinic acid, 50 mg.

[^4]: *B*^*0*^*AT* = Na^+^ dependent neutral amino acid transporter; *ATB*^*0*,\ *+*^ = Na^+^ and Cl^−^ dependent neutral and cationic amino acid transporter; *b*^*0*,\ *+*^*AT* = Na^+^-independent cationic and zwitterionic amino acid transporter; *SAT1* = diamine acetyltransferase 1; LAT1 = Na^+^-independent branched-chain and aromatic amino acid transporter; *y*^*+*^*LAT2* = Na ^+^ -independent cationic & Na^+^-dependent neutral amino acid; *MCT1* = proton dependent monocarboxylate transporter 1; *NHE3* = Na^+^-H^+^ exchanger; *MAT1* = methionine adenosyltransferase *1*; *MrsA* = methionine sulfoxide reductase *A*; *Trx* = thioredoxin; *Grx* = glutaredoxin; *GSR* = glutathione reductase; *GSS* = glutathione synthetase; *GAPDH* = glyceraldehyde-3-phosphate dehydrogenase.

[^5]: ADG = average daily gain; ADFI = average daily feed intake; FCR = feed conversion ratio; DLM = DL-methionine; HMTBa = DL-2-hydroxy-4-methylthio-butanoic acid; BW = body weight.

[^6]: ^a,\ b^ Within a column, means sharing the same superscripts are not significantly different from each other at *P* \< 0.05.

[^7]: GPx = glutathione peroxidase; T-GSH = total glutathione; GSSG = glutathione disulfide; GSH = glutathione; DLM = DL-methionine; HMTBa = DL-2-hydroxy-4-methylthio-butanoic acid.

[^8]: ^a,\ b^ Within a column, means sharing the same superscripts are not significantly different from each other at *P* \< 0.05.

[^9]: T-GSH = total glutathione; GSSG = glutathione; GSH = glutathione; DLM = DL-methionine; HMTBa = DL-2-hydroxy-4-methylthio-butanoic acid.

[^10]: ^a,\ b^ Within a column, means sharing the same superscripts are not significantly different from each other at *P* \< 0.05.

[^11]: *MAT1* = methionine adenosyltransferase 1; *MrsA* = methionine sulfoxide reductase *A*; *Trx* = thioredoxin; *Grx* = glutaredoxin; *GSR* = glutathione reductase; *GSS* = glutathione synthetase; DLM = DL-methionine; HMTBa = DL-2-hydroxy-4-methylthio-butanoic acid.

[^12]: ^a,\ b^ Within a column, means sharing the same superscripts are not significantly different from each other at *P* \< 0.05.

[^13]: *B*^*0*^*AT* = Na^+^ dependent neutral amino acid transporter; *ATB*^*0*,\ *+*^ = Na^+^ and Cl^−^ dependent neutral and cationic amino acid transporter; *b*^*0*,\ *+*^*AT* = Na^+^-independent cationic and zwitterionic amino acid transporter; *SAT1* = diamine acetyltransferase 1; LAT1 = Na^+^-independent branched-chain and aromatic amino acid transporter; *y*^*+*^*LAT2* = Na^+^-independent cationic & Na^+^-dependent neutral amino acid; *MCT1* = proton dependent monocarboxylate transporter 1; *NHE3* = Na^+^-H^+^ exchanger; DLM = DL-methionine; HMTBa = DL-2-hydroxy-4-methylthio-butanoic acid.

[^14]: ^a,\ b^ Within a column, means sharing the same superscripts are not significantly different from each other at *P* \< 0.05.
